Mainstream

Simmons First National Non-GAAP EPS of $0.44 beats by $0.05, revenue of $214.2M misses by $2.46M

Simmons First National Non-GAAP EPS of $0.44 beats by $0.05, revenue of $214.2M misses by $2.46M

Post ContentsfncRead More

You might also be interested in reading Lenz Therapeutics outlines Q4 2025 launch plans for LNZ100 amid FDA review progress.

July 17, 2025
In Mainstream